checkAd

    Swiss Medica ein MUSS für alle !!!! - 500 Beiträge pro Seite

    eröffnet am 22.06.05 12:37:48 von
    neuester Beitrag 23.06.05 07:29:49 von
    Beiträge: 2
    ID: 988.776
    Aufrufe heute: 0
    Gesamt: 207
    Aktive User: 0


     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 22.06.05 12:37:48
      Beitrag Nr. 1 ()
      Seht euch nur einmal auf der Homepage um, eine gute Nachricht nach der anderen - das wird noch eine der besten Aktien werden.

      www.swissmedica.com

      LG
      Avatar
      schrieb am 23.06.05 07:29:49
      Beitrag Nr. 2 ()
      Es geht weiter mit den positiven News :lick::laugh:

      6/21/2005 12:30:18 PM ET News Release Index


      SWISS MEDICA’S O24™ PAIN NEUTRALIZER ADDS NEW RETAILERS

      FOR IMMEDIATE RELEASE

      Stock Symbol: OTC BB: SWME
      June 21, 2005

      SWISS MEDICA’S O24™ PAIN NEUTRALIZER ADDS NEW RETAILERS

      Toronto, Ontario Canada – Swiss Medica Inc. (OTC BB: SWME) is pleased to announce that the Company’s flagship O24™ Pain Neutralizer product is now available in more major retailers in the United States and Canada. Currently, O24™ Pain Neutralizer can now be found in more than 13,000 stores throughout the United States and Canada. Retail store locators for O24™ Pain Neutralizer can be found on our web site: www.O24zone.com . Swiss Medica will continue its extensive and aggressive marketing, public relations, and sampling programs to support the increased national distribution for O24™.

      “We are excited to continue adding major pharmacies to our growing list of customers,” announced Tom Quinn, Executive Vice President. “O24™ is now available for the first time in major markets such as New England, Texas, and Florida, including important metropolitan areas, such as Boston, Dallas, Houston, Atlanta, Miami, Tampa, and Orlando.”

      Due to the corporate policies of some of our retail customers that do not allow for press releases, we have not named specific retailers in this press release and are referring our shareholders and other investors to our O24™ product website for updated retailers who are selling O24™ Pain Neutralizer.

      About Swiss Medica Inc.

      Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica`s mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com, www.O24zone.com and www.pmsescape.com.

      Swiss Medica`s flagship product, the O24™ Pain Neutralizer, holds US Patent #6,444,238B1. The O24™ pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals in the United States, Canada and in Europe. O24™ is widely available throughout Canada in leading pharmacies and natural food stores. It is currently sold in an increasing number of pharmacies throughout the United States. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest pharmacy.

      Swiss Medica also manufactures PMS Escape® which holds US Patent #’s 5760014 and 5612320. PMS Escape® is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce changes in mood and appetite that women experience during the premenstrual period. Customers can also visit www.pmsescape.com for additional information and ordering details.

      Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to international sales and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica`s products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica`s periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities.


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.
      Swiss Medica ein MUSS für alle !!!!